| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |